We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAY
3001
DELISTED
Verifone Systems Inc
PAY
$6K ﹤0.01%
310
-17,433
-98% -$290K
MATR
3002
DELISTED
Mattersight Corp.
MATR
$6K ﹤0.01%
+1,575
New +$5.85K
PQ
3003
DELISTED
Petroquest Energy Inc Wd
PQ
$6K ﹤0.01%
1,859
-232
-11% -$869
RT
3004
DELISTED
Ruby Tuesday Georgia
RT
$6K ﹤0.01%
+1,764
New +$5.37K
ASBB
3005
DELISTED
ASB Bancorp Inc
ASBB
$6K ﹤0.01%
199
-101
-34% -$2.77K
GUID
3006
DELISTED
Guidance Software, Inc.
GUID
$6K ﹤0.01%
+870
New +$5.54K
NVDQ
3007
DELISTED
Novadaq Technologies Inc.
NVDQ
$6K ﹤0.01%
790
-1,666
-68% -$15.1K
SNOW
3008
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
$6K ﹤0.01%
352
+291
+477% +$4.99K
SWC
3009
DELISTED
Stillwater Mining Co
SWC
$6K ﹤0.01%
386
-11,489
-97% -$164K
IBTX
3010
DELISTED
Independent Bank Group, Inc.
IBTX
$6K ﹤0.01%
90
-91
-50% -$4.92K
GRA
3011
DELISTED
W.R. Grace & Co.
GRA
$6K ﹤0.01%
93
-821
-90% -$56.1K
FENX
3012
DELISTED
Fenix Parts, Inc.
FENX
$6K ﹤0.01%
+2,175
New +$7.4K
BSQR
3013
DELISTED
BSQUARE Corporation
BSQR
$6K ﹤0.01%
1,015
+236
+30% +$1.2K
AAXJ icon
3014
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.77B
$5K ﹤0.01%
87
-44,905
-100% -$2.59M
AGZD icon
3015
WisdomTree Trust WisdomTree Interest Rate Hedged US Aggregate Bond Fund
AGZD
$135M
$5K ﹤0.01%
200
-600
-75% -$14.4K
ALKS icon
3016
Alkermes
ALKS
$8.25B
$5K ﹤0.01%
85
+1
+1% +$53
ALSN icon
3017
Allison Transmission
ALSN
$9.82B
$5K ﹤0.01%
142
-258
-65% -$8.03K
ANIP icon
3018
ANI Pharmaceuticals
ANIP
$1.78B
$5K ﹤0.01%
83
-739
-90% -$45.2K
ASPN icon
3019
Aspen Aerogels
ASPN
$518M
$5K ﹤0.01%
1,090
-2,530
-70% -$12.3K
ATXS
3020
DELISTED
Astria Therapeutics
ATXS
$5K ﹤0.01%
24
+4
+20% +$979
BRID icon
3021
Bridgford Foods
BRID
$56.5M
$5K ﹤0.01%
408
-344
-46% -$4.18K
CROX icon
3022
Crocs
CROX
$6.55B
$5K ﹤0.01%
751
+747
+18,675% +$5.79K
CUK
3023
DELISTED
Carnival PLC
CUK
$5K ﹤0.01%
100
-12
-11% -$597
CXH
3024
DELISTED
MFS Investment Grade Municipal Trust
CXH
$5K ﹤0.01%
+500
New +$4.86K
DARE icon
3025
Dare Bioscience
DARE
$21M
$5K ﹤0.01%
58
+39
+205% +$3.72K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.